Christopher Ehrlich - Director, Transcept Pharmaceuticals Inc

As of April 11, 2013


Christopher Ehrlich Net Worth

  • Net worth is estimated to be at least $13.46M
  • Owns at least 1,983,884 units of Transcept Pharmaceuticals Inc stock

Christopher Ehrlich Trading

  • Largest purchase of shares was 732,076 units , worth over $4.96M on September 22, 2011
  • In total has made about 8 transactions over 4 years
  • Usually trades in January, with the busiest year in 2011, 2010 and 2013
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christopher Ehrlich Mailing Address

  • Mailing address is 499 Illinois Street, Suite 200 San Francisco CA 94158 CA

Transcept Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 1,470 units sold on December 17, 2013 by Roumell Asset Management Llc worth over $5.2K
  • In the last 4 years, insiders at Transcept Pharmaceuticals Inc sold an estimated value of $6.52M and bought an estimated value of $9.99M
  • The most active traders are Roumell Asset Management Llc,  Glenn Oclassen, President and CEO,  and Marilyn Wortzman, VP
  • Insider trading is most common in February, with the busiest year in 2011

Transcept Pharmaceuticals Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1